OAC
CRDF icon

OMERS Administration Corp’s Cardiff Oncology CRDF Stock Holding History

OMERS Administration Corp’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-51,100
Closed -$273K – 1083
2024
Q1 		$273K Buy
+51,100
New +$136K ﹤0.01% 258

Other funds holding CRDF

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $3.38B AUM 214.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

OMERS Administration Corp's CRDF Position: Q2 2024 in Review

OMERS Administration Corp sold out of Cardiff Oncology (CRDF) in Q2 2024, closing a stake of 51,100 shares — an estimated $273K sold.

OMERS Administration Corp first reported a position in CRDF in Q1 2024 and held it in 1 quarter. The position peaked at $273K in Q1 2024. 90 funds tracked by Wall St. Rank hold CRDF as of Q2 2024.

  • OMERS Administration Corp reported no remaining Cardiff Oncology position as of Q2 2024 after selling out during the quarter.
  • OMERS Administration Corp sold 51,100 Cardiff Oncology shares in Q2 2024, an estimated $273K.
  • OMERS Administration Corp first reported a position in Cardiff Oncology in Q1 2024 and held it in 1 quarter.
  • OMERS Administration Corp's Cardiff Oncology position peaked at $273K in Q1 2024.
  • 90 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2024.

Based on OMERS Administration Corp's 13F filing for Q2 2024, filed 13 Aug 2024.